MarketResearchReports.Biz

Autism Spectrum Disorder Treatment Market - Global Industry Analysis, Size, Share, Growth

MarketResearchReports.Biz presents this most up-to-date research on "Autism Spectrum Disorder Treatment "

 

Albany, NY -- (SBWIRE) -- 06/26/2014 -- Autism Spectrum Disorder Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2013 - 2019

Autism spectrum disorder (ASD) is a group of multifaceted neurodevelopment disabilities characterized by social, behavioral and communication challenges. This condition is characterized by communication difficulties, social impairment and repetitive and stereotyped behavioral patterns. It is a spectrum condition because while all people affected with autism share some similar difficulties, the level of medical condition affects them in different ways. Symptoms of ASD vary widely and it may sometimes go unrecognized especially in mildly affected children. Early indicators include loss of language or social skills, lack of response, poor eye contact, no single words or two-word phrases by the age of 2 years. If left unrecognized by the age of 3 years, one may recognize later through impaired ability to make friends, stereotyped or unusual use of language, inability to initiate or withstand a conversation with others; varying specific routines or rituals and impairment or absence of imaginative and social interactions.

Browse Full Report With Toc:
http://www.marketresearchreports.biz/analysis-details/autism-spectrum-disorder-treatment-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

Presently, there are no medications that can treat ASD or its core symptoms. It is an underserved market with only two FDA approved drugs Abilify (aripiprazole) and risperidone. These drugs belong to the anti-psychotics therapeutic class, but are approved for the treatment of irritability associated with autistic disorder. Besides, certain other classes of drugs such as antidepressants, anticonvulsants and stimulants are prescribed off-label for reducing autism related neurological challenges.

Patent expiration of Abilify will lead to decline in the market growth which is expected to offset by new introductions which may improve the therapeutic benefits. The growth of this market is primarily attributed to the increasing prevalence of ASD. According to CDC, average prevalence of ASD in Asia, Europe and North America is 1%. Further, the estimates state that the prevalence rate has risen form 1 in 150 children in 2000 to 1 in 68 children in 2010.

Abilify is a product of Bristol-Myers Squibb and Otsuka Holdings Co., Ltd. While, risperidone is a generic market with many key players such as Janssen Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Actavis, Inc., Mylan Pharmaceuticals, Inc., Ranbaxy Laboratories Limited and Sun Pharmaceutical Industries Limited.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

- North America
- Asia Pacific
- Europe
- Rest of the World

To Get Download Full Report with Toc:
http://www.marketresearchreports.biz/sample/toc/206062

This report provides comprehensive analysis of

- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

To Read Complete Report with Toc:
http://www.marketresearchreports.biz/analysis/206062

Reasons for Buying this Report

- This report provides pin-point analysis for changing competitive dynamics

- It provides a forward looking perspective on different factors driving or restraining market growth

- It provides a technological growth map over time to understand the industry growth rate

- It provides a seven-year forecast assessed on the basis of how the market is predicted to grow

- It helps in understanding the key product segments and their future

- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

- It provides distinctive graphics and exemplified SWOT analysis of major market segments

Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
Tel: +1-518-618-1030
E-mail: sales@marketresearchreports.biz